Japan, Aug. 24 -- INSTITUTE DE CANCEROLOGIE DE LOUEST,NANTES UNIV,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,INSTITETE NATIONAL SANTE RECH MEDICAL,OGD2 PHARMA has got intellectual property rights for 'USE OF ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE TO IMPROVE THERAPEUTIC POTENTIAL OF DRUGS.' Other related details are as follows:
Application Number: JP,2023-014183
Category (FI): A61K45/00,A61P35/04,A61P35/02,A61K31/4188,A61K31/4725,A61K31/203,A61P43/00,121,A61K39/395@N,A61K39/395@D,C07K16/28,A61K31/713,A61K31/7088,A61K31/4745,A61K31/704,A61K47/68,A61P35/00,A61K31/675
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Feb. 1, 2023
Publication Date: May 12, 2023
The original document can be viewed at: ...